News & Updates
Filter by Specialty:

Dupilumab trumps MTX, cyclosporine in paediatric AD
The use of dupilumab in children with moderate-to-severe atopic dermatitis (AD) results in greater improvements in AD severity, better adherence, and fewer treatment-emergent adverse events (TEAEs) than methotrexate (MTX) or cyclosporine, as shown by 2-year interim results from the PEDISTAD study.
Dupilumab trumps MTX, cyclosporine in paediatric AD
03 Feb 2025
Use of APCC in an elderly AHA patient requiring invasive procedures
An 81-year-old female presented to a private hospital with painful right upper arm swelling and bruising in August 2023. There was no history of trauma or contusion other than a minor sprain 2 weeks prior to presentation. There was also no family history of bleeding tendency. The patient had multiple comorbidities: hypertension, hyperlipidaemia, type 2 diabetes (T2D), overweight (body weight, 60 kg; BMI, 25 kg/m2), osteoarthritis of both knees, and vitamin B12 deficiency.